&nbsp;

cancerplan6summary.pdf

Jan 2025

Document

cancerplan6.pdf

Jan 2025

Regimen

CRBPPEME+AMIV

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin,

amivantamab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2025

Comprendre le résultat de votre test de dépistage du cancer du col de l’utérus

Cette page s’adresse aux personnes porteuses d’un type de virus du papillome humain (VPH) pouvant parfois causer un cancer du col de l’utérus. Si...

Regimen

CHOP+R

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Palliative

Funding:

ODB - General Benefit

prednisone

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

Document

CART-cellTherapyforAdult RelapsedrefractoryLymphomaThirdorSubsequentLine.pdf

Dec 1969

Document

CART-cellTherapyforAdultRelapsedrefractoryLymphomaThirdorSubsequentLine.pdf

Dec 1969

Document

ClearCellOvarianCancerTreatmentPathwayMap.pdf

Dec 1969

Drug

atezolizumab (subcut)

Other Name(s): Tecentriq® SC

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Regimen

CRBPPACL+PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISPPEME+PEMB

Cancer Type:

Gastrointestinal,

Mesothelioma (Peritoneal),

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used: